Phanes Therapeutics signs clinical supply agreement with Roche
US-based biopharmaceutical company Phanes Therapeutics has announced a clinical supply agreement with Roche for a combination therapy study. The collaboration will focus on evaluating PT217, Phanes’ first-in-class bispecific antibody, in combination with …